RxDoctor Payments Data

Eric Fulkerson, MD

Orthopaedic Trauma · Walnut Creek, CANPI 1568581429

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $79,789 of the $117,274 with a category attached, or 68.0%. 28 manufacturers reported payments, led by Globus Medical at 47.2% of the total. Reporting peaked in 2020 at $75,920 and has fallen 88.1% since, to $9,049 in 2025.

$117,274in general payments, 2019–2025

Across 146 payments — averaging $803.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$55K
  • Conventus Orthopaedics, Inc.$55K
  • Flower Orthopedics Coporation$2K
  • Si-bone, Inc.$1K
  • Stryker$1K
  • Zimmer Biomet$763
  • plus $2K from 22 others

What the payments were for

  • Royalty or licence$16,50514%
  • Consulting fees$79,78968%
  • Speaking & faculty fees$7,6006%
  • Travel & lodging$9,0508%
  • Food & beverage$4,3304%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$117,274 in reported general payments places this provider in the 80th percentile of 106 orthopaedic trauma providers in California.

See all orthopaedic trauma providers in California

Medicare billing

Part B allowed, 2024
$251,205
Medicare patients
399
Services billed
1,299

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam53$190
Ibuprofen12$35

Paid to pharmacies, not to this prescriber.

Other orthopaedic trauma in Walnut Creek

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →